News | March 20, 2025
ZIM Laboratories receives marketing authorization for Dimethyl Fumarate in Portugal
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
Aims to achieve CDMO sales of US$ 400 million by 2028
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Subscribe To Our Newsletter & Stay Updated
